Motivational interviewing and urine cotinine feedback to stop passive smoke exposure in children predisposed to

Sasha G Hutchinson1, Gerard van Breukelen2, Constant P van Schayck3

  • 1Department of Paediatric Pulmonology, Maastricht University Medical Center (MUMC+)/CAPHRI School for Public Health and Primary Care, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. sasha.hutchinson@maastrichtuniversity.nl.

Scientific Reports
|November 15, 2017
PubMed

Insights

Motivational interviewing and urine cotinine feedback effectively reduced passive smoking (PS) in children at risk for asthma. This intervention shows promise for protecting children

Area of Science:

  • Environmental Health
  • Pediatrics
  • Public Health

Background:

  • Secondhand smoke exposure poses significant health risks to children, particularly those with asthma.
  • Children with asthma are particularly vulnerable to the adverse effects of passive smoking (PS).

Purpose of the Study:

  • To evaluate the effectiveness of a combined motivational interviewing (MI) and urine cotinine feedback program in reducing PS in children at high risk for asthma.
  • To assess the impact of the intervention on families' ability to stop PS exposure in their children.

Main Methods:

  • A randomized controlled trial involving 58 families with children aged 0-13 years at high risk for asthma and PS exposure.
  • Intervention group received 6 monthly sessions of MI and cotinine feedback; control group received standard measurements.
  • Primary outcome: percentage of families stopping PS, verified by child's urine cotinine levels (<10 μg/l).

Main Results:

  • After 6 months, 27% of families in the intervention group reported stopping PS, compared to 7% in the control group (unverified report).
  • Verified parental reports showed a similar trend (23% vs. 7%), though not statistically significant.
  • The intervention demonstrated a probable positive effect on reducing PS in children.

Conclusions:

  • The motivational interviewing and urine cotinine feedback program appears to be a potentially effective strategy for reducing passive smoking in children.
  • A longer intervention duration may be necessary to achieve statistically significant and lasting effects.
  • Further research with larger sample sizes is warranted to confirm these findings.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
874
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.9K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K